Recombinant coagulation factor VIIa in the management of bleeding in patients with von Willebrand disease type 2A

Transfus Apher Sci. 2004 Aug;31(1):75-7. doi: 10.1016/j.transci.2004.05.002.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Factor VIIa / therapeutic use*
  • Female
  • Humans
  • Intraoperative Care
  • Middle Aged
  • Recombinant Proteins / therapeutic use
  • von Willebrand Diseases / therapy*

Substances

  • Recombinant Proteins
  • Factor VIIa